Picture of argenx SE logo

ARGX argenx SE News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapMomentum Trap

Brief: Argenx Expects Combined 2024 R&D and SGA Expenses Of Less Than $2 Bln

May 9 (Reuters) - argenx SE  ARGX.BR :
    * REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES
BUSINESS UPDATE
    * TOTAL OPERATING EXPENSES WERE - USD 506 MLN VERSUS - USD
334
MLNLAST YEAR
    * CASH, CASH EQUIVALENTS AND CURRENT FINANCIAL ASSETS
TOTALLED USD
3.1 BLN AS OF MARCH 31, 2024
    * EXPECTS TO UTILIZE UP TO USD 500 MLN OF NET CASH IN 2024
ON
THESE ANTICIPATED OPERATING EXPENSES AS WELL AS WORKING CAPITAL
AND CAPITAL EXPENDITURES
    * EXPECTS ITS COMBINED RESEARCH AND DEVELOPMENT AND SELLING,
GENERAL AND ADMINISTRATIVE EXPENSES IN 2024 TO BE LESS THAN USD
2 BLN

Source text for Workspace:  ID:nGNE8SNqRq 
Further company coverage:  ARGX.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on argenx SE

See all news